Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Search result
- 65472
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Swissmedic Registration
65472
Date of registration
03.03.2016
Company name
MSD Merck Sharp & Dohme AG
Revision date
Valid until
Indication
Date of market entry
Index Therapeuticus (BSV)
Revocation Date
Index Therapeuticus (Swissmedic)
08.01.30.
Information for professionals
IP
Seq.-No.
Product
Description
Galenic form
ATC-classification
01
Zerbaxa 1.5 g
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung (Ceftolozanum 1000 mg, Tazobactame 500 mg)
J01DI54
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
